Plante Hendrick, Picard Serge, Mancini Joseph, Borgeat Pierre
Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du CHUQ and Faculté de Médecine, Université Laval, 2705 Boulevard Laurier, Quebec, G1V 4G2, Canada.
Biochem J. 2006 Jan 1;393(Pt 1):211-8. doi: 10.1042/BJ20050669.
FLAP (5-lipoxygenase-activating protein) is a nuclear transmembrane protein involved in the biosynthesis of LTs (leukotrienes) and other 5-LO (5-lipoxygenase) products. However, little is known about its mechanism of action. In the present study, using cross-linkers, we demonstrate that FLAP is present as a monomer and a homodimer in human PMN (polymorphonuclear cells). The functional relevance of the FLAP dimer in LT biosynthesis was assessed in different experimental settings. First, the 5-LO substrate AA (arachidonic acid) concomitantly disrupted the FLAP dimer (at > or =10 microM) and inhibited LT biosynthesis. Secondly, using Sf9 cells expressing active and inactive FLAP mutants and 5-LO, we observed that the FLAP mutants capable of supporting 5-LO product biosynthesis also form the FLAP dimer, whereas inactive FLAP mutants do not. Finally, we showed that FLAP inhibitors such as MK-0591 which block LT biosynthesis in human PMN, disrupt the FLAP dimer in PMN membranes with a similar IC50. The present study demonstrates that LT biosynthesis in intact cells not only requires the presence of FLAP but its further organization into a FLAP homodimer.
5-脂氧合酶激活蛋白(FLAP)是一种核跨膜蛋白,参与白三烯(LTs)及其他5-脂氧合酶(5-LO)产物的生物合成。然而,其作用机制尚不清楚。在本研究中,我们使用交联剂证明,FLAP在人多形核细胞(PMN)中以单体和同二聚体形式存在。在不同的实验条件下评估了FLAP二聚体在LT生物合成中的功能相关性。首先,5-LO底物花生四烯酸(AA)在浓度≥10μM时可同时破坏FLAP二聚体并抑制LT生物合成。其次,利用表达活性和非活性FLAP突变体以及5-LO的昆虫细胞(Sf9),我们观察到能够支持5-LO产物生物合成的FLAP突变体也能形成FLAP二聚体,而非活性FLAP突变体则不能。最后,我们发现,像MK-0591这样能阻断人PMN中LT生物合成的FLAP抑制剂,能以相似的半数抑制浓度(IC50)破坏PMN膜中的FLAP二聚体。本研究表明,完整细胞中的LT生物合成不仅需要FLAP的存在,还需要其进一步组装成FLAP同二聚体。